Welcome to the Brain & Behavior Lab Monthly Newsletter Vol. 1, Issue 3, July 2024

Dr. Modestino's Director's Blog

 

July 2024: A Month in Review of Neuroscience News Articles Referring to Original Research

 
July 2024 Neuroscience

We are pleased to announce that Dr. Modestino just accepted an offer to be an Editorial Board Member for the journal Brain Sciences under the section of Behavioral Neuroscience! Please congratulate him!

 

Brain Sciences

Breaking news!

Our Case Study Publication about RSD has just been published with Dr. Dodson!

 

Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series. 

 
RSD Publication

Dr. Dodson's latest Talk: "Rethinking ADHD: A Treatment (R)evolution"

Password: CwmwithDodson1234

Dr. Dodson has an upcoming book titled Treating ADHD. You can get updates from Dr. Dodson's website.

Dr. Dodson's website

Breaking news!

Dr. Blum's group is about to publish this study in the Journal of Personalized Medicine: A comprehensive 4-layered in silico pharmacogenomics analysis on the Genetic Addiction Risk Severity (GARS) Test: Predominance of genetic evidence support GARS as a novel personalized Pre-addiction assessment tool in the opioid crisis era.

 
Press Release

Dr. Carey's Blog

The Eyes: Our Unexpected Guardians Against Brain Pathogens 

 
The Eyes: Our Unexpected Guardians Against Brain Pathogens

Dr. Carey has been elected to the position of Co-Chair of the Department of Psychology at Curry College! Please congratulate her!

Our Current Research:

We have two survey studies: one about Rejection Sensitivity Dysphoria (RSD) in ADHD and another about the triggers of attacks in those with migraines and narcolepsy. We are looking for volunteers for our research! Click the link below!

 
Current Research

 

 
Publications

Here is a list of our recent publications:

 

  • Dodson, W.W., Modestino, E.J., Titiz-Ceritoğlu, H., & Zayed, B. (2024) Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series.  Acta Scientific Neurology, 7(8): 23-30. DOI: 10.31080/ASNE.2024.07.0762

     

  • Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, et al. (2024). Solving the Global

    Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration. Therapy J Addict Psychiatry 8(1): 50-96. (Drs. Blum, Modestino, and Thanos are co-authors)

​

  • Modestino, E.J., Bowirrat A, Baron, D., Thanos, P.K., Hanna, C., Bagchi, D., Braverman, E.R., Dennen, C.A., Badgaiyan, R.D., Pollack, A.R., Lewandrowski, K.-U., Sharafshah, A., Gold, M.S., & Blum, K. (2024) Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs. J Addict Psychiatry, 8(1): 34-49

​

  • Modestino, E.J., Bowirrat, A., Lewandowski, K.-U., Sharafshah,  A., Badgaiyan, R.D., Thanos, P.K., Baron, D., Dennen, C.A., Elman, I., Sunder, K., Murphy, K.T., & Blum, K. (2024). Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss.  Acta Scientific Neurology, 7(5): 12-18.  DOI: 10.31080/ASNE.2024.07.0731

​

  • Dodson, W.W., & Modestino, E.J. (2024). Have we placed the cart before the horse by using alpha-2A agonists to treat rejection sensitivity dysphoria in ADHD? Current Psychopharmacology, e050424228696.  DOI: 10.2174/0122115560297397240404071044

     

  • Blum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., Dennen, C. A., Braverman, E. R., Soni, D., Carney, P., Khalsa, J., Modestino, E. J., Barh, D., Bagchi, D., Badgaiyan, R. D., … Gold, M. S. (2024). Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences. Gene & Protein in Disease, 3(1), 1966. https://doi.org/10.36922/gpd.1966

Visit our lab shop for lab merch!

 
Lab Shop
Subscribe to our monthly newsletter
Subscribe

Visit our social media accounts

Check out our site  
This email was created with Wix.‌ Discover More